InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

01 May 2025

Name:	QRXPHARMA LTD (QRX)
Date of Listing:	25 May 2007
Date of Delisting:	23 May 2018

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 23 May 2018.

Legal Status: (updated monthly)

ACN: 102 254 151

To our knowledge this is a current registered entity, not in any form of external administration. If you have questions about your shareholding they may be taken up with us here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

The securities in this entity, in our opinion, are of little or no value. We have made that assessment by reference to the circumstances leading to a suspension and/or delisting, the length of a suspension, share trading history and last on-market share price, most recent financial and cash flow statements, prospects (including likelihood of re-financing), and other factors including in particular whether the entity is in external administration. If you are seeking to crystallise a capital loss on your securities, that process can be easily and quickly initiated at our online Worthless Shares facility here: https://www.delisted.com.au/sell-worthless-and-other-securities/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

QRXPHARMA LTD(QRX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of QRX:

(4 out of 5)

COMPANY WEBSITE:

QRX website

QRX email

QRX investorRelations

QRX announcements

QRX directors

REGISTRY:

Level 12, 680 George Street Sydney NSW 2000

Tel : 61 1300 554 474
Fax : 02 9287 0303
RegistryWebsite RegistryEmail

Company details

Address: Suite 201, 697 Burke Road, Camberwell VIC 3124
Tel: +61 3 9092 0475 Fax: +61 2 8920 0314

Date first listed: 25/05/2007
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: The Company is a clinical stage specialty pharmaceutical company focused on developing and commercialising therapies to treat disorders of the central nervous system

News & Events

Expand this box to read and print

Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.	05/03/2025
The status of the organisation has been changed from Strike-off Action in Progress to Registered as of 17/06/2024	17/06/2024
Strike-off action has been initiated against the company as of 30/05/2024	30/05/2024
this company changed its name to Guardian Medical Solutions Limited on or about 18 January 2022	10/06/2022
we understand that on or about 07/01/2022 the share capital of the company was consolidated on the basis that every 10 Shares on issue at the time was consolidated into 1 Share	10/06/2022
delisted from the commencement of trading on Wednesday, 23 May 2018 pursuant to Listing rule 17.12	23/05/2018
we understand the company failed and ASX removed the company from listing as its securities have not been quoted for three years	23/05/2018
Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Monday 22 August 2016 will have its securities suspended from official quotation before the commencement of trading on Tuesday 23 August 2016. The company has not paid its annual listing fees in respect of the year ending 30 June 2017 but the securities are already suspended from official quotation.	23/08/2016
Deed of Company Arrangement is effectuated and company emerges from external administration	23/12/2015
The securities of QRxPharma Limited will be suspended from quotation immediately, pending the appointment of sufficient directors to comply with section 201A(2) of the Corporations Act 2001. Security Code: QRX	22/05/2015
company placed into Voluntary Administration and has appointed Timothy Heesh and Amanda Lott of TPH Insolvency to act as Joint and Several Administrators	22/05/2015
the suspension of trading in the securities of QRxPharma Limited will be lifted immediately, following receipt of an announcement in respect of a fully underwritten placement and rights issue	16/11/2009
the securities of QRxPharma Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to a proposed capital raising	13/11/2009

Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.	05/03/2025
The status of the organisation has been changed from Strike-off Action in Progress to Registered as of 17/06/2024	17/06/2024
Strike-off action has been initiated against the company as of 30/05/2024	30/05/2024
this company changed its name to Guardian Medical Solutions Limited on or about 18 January 2022	10/06/2022
we understand that on or about 07/01/2022 the share capital of the company was consolidated on the basis that every 10 Shares on issue at the time was consolidated into 1 Share	10/06/2022
delisted from the commencement of trading on Wednesday, 23 May 2018 pursuant to Listing rule 17.12	23/05/2018
we understand the company failed and ASX removed the company from listing as its securities have not been quoted for three years	23/05/2018
Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Monday 22 August 2016 will have its securities suspended from official quotation before the commencement of trading on Tuesday 23 August 2016. The company has not paid its annual listing fees in respect of the year ending 30 June 2017 but the securities are already suspended from official quotation.	23/08/2016
Deed of Company Arrangement is effectuated and company emerges from external administration	23/12/2015
The securities of QRxPharma Limited will be suspended from quotation immediately, pending the appointment of sufficient directors to comply with section 201A(2) of the Corporations Act 2001. Security Code: QRX	22/05/2015
company placed into Voluntary Administration and has appointed Timothy Heesh and Amanda Lott of TPH Insolvency to act as Joint and Several Administrators	22/05/2015
the suspension of trading in the securities of QRxPharma Limited will be lifted immediately, following receipt of an announcement in respect of a fully underwritten placement and rights issue	16/11/2009
the securities of QRxPharma Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to a proposed capital raising	13/11/2009

Your browser may reflect a date of printing in American format.

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Most recent comments

When is this company going to be fully delisted

09/08/2017 09:13:18

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Edward Rudnic	CEO	14/02/2012
Christopher Campbell	CFO	01/03/2007
John Rainbow	Director	11/10/2016
Tim Heesh	Director	11/10/2016
Anthony Jefferies	Director	23/03/2018
Cameron Jones	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.